Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
Hiroyuki Onodera,1 Takeru Urayama,2 Kazue Hirota,3 Kazuhiro Maeda,3 Ritsuko Kubota-Koketsu,3,4 Kazuo Takahashi,5 Katsuro Hagiwara,6 Yoshinobu Okuno,3 Kazuyoshi Ikuta,3,4 Mikihiro Yunoki,2,4,6 1Medical Information Department, 2Research and Development Division, Japan Blood Products Organization, Toky...
Saved in:
Main Authors: | Onodera H, Urayama T, Hirota K, Maeda K, Kubota-Koketsu R, Takahashi K, Hagiwara K, Okuno Y, Ikuta K, Yunoki M |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/f64a87ea46874150b46e5d638c1f1928 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7
by: Kubota-Koketsu R, et al.
Published: (2021) -
Neutralizing activities of human immunoglobulin derived from donors in Japan against mosquito-borne flaviviruses, Japanese encephalitis virus, West Nile virus, and dengue virus
by: Yunoki M, et al.
Published: (2016) -
Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010
by: Ikuta K, et al.
Published: (2012) -
The Usage of Influenza Vaccine to Prevent Seasonal Influenza during Pandemic COVID-19
by: Yelvi Levani, et al.
Published: (2021) -
Determination of the Relationship Between Kobayashi, Sano, and Egami Criteria and Prevalence of Intravenous Immunoglobulin Resistance and Coronary Artery Aneurysm in Iranian Children with Kawasaki Disease
by: Shashaani N, et al.
Published: (2020)